Background: A leadless intracardiac transcatheter pacing system has been designed to avoid the need for a pacemaker pocket and transvenous lead.
Methods: In a prospective multicenter study without controls, a transcatheter pacemaker was implanted in patients who had guideline-based indications for ventricular pacing. The analysis of the primary end points began when 300 patients reached 6 months of follow-up. The primary safety end point was freedom from system-related or procedure-related major complications. The primary efficacy end point was the percentage of patients with low and stable pacing capture thresholds at 6 months (≤2.0 V at a pulse width of 0.24 msec and an increase of ≤1.5 V from the time of implantation). The safety and efficacy end points were evaluated against performance goals (based on historical data) of 83% and 80%, respectively. We also performed a post hoc analysis in which the rates of major complications were compared with those in a control cohort of 2667 patients with transvenous pacemakers from six previously published studies.
Results: The device was successfully implanted in 719 of 725 patients (99.2%). The Kaplan-Meier estimate of the rate of the primary safety end point was 96.0% (95% confidence interval [CI], 93.9 to 97.3; P<0.001 for the comparison with the safety performance goal of 83%); there were 28 major complications in 25 of 725 patients, and no dislodgements. The rate of the primary efficacy end point was 98.3% (95% CI, 96.1 to 99.5; P<0.001 for the comparison with the efficacy performance goal of 80%) among 292 of 297 patients with paired 6-month data. Although there were 28 major complications in 25 patients, patients with transcatheter pacemakers had significantly fewer major complications than did the control patients (hazard ratio, 0.49; 95% CI, 0.33 to 0.75; P=0.001).
Conclusions: In this historical comparison study, the transcatheter pacemaker met the prespecified safety and efficacy goals; it had a safety profile similar to that of a transvenous system while providing low and stable pacing thresholds. (Funded by Medtronic; Micra Transcatheter Pacing Study ClinicalTrials.gov number, NCT02004873.).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1056/NEJMoa1511643 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Short-Term Synchronization of an Intracardiac Leadless Pacemaker With a Transvenous Atrial Pacemaker in a Sedentary Patient.
JACC Case Rep
November 2024
Division of Cardiovascular Medicine, Hillel Yaffe Medical Center, The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
We herein describe a case of successful atrioventricular synchrony at an 8-week follow-up in a patient who received a leadless pacemaker for recurrent right ventricular lead failures and had a pre-existing atrial transvenous pacemaker. Given the significant hemodynamic improvements, careful initial programming and adjustments during follow-up are needed.
View Article and Find Full Text PDFFirst leadless pacemaker implant in a pediatric patient via the femoral vein using intracardiac echocardiography guidance.
HeartRhythm Case Rep
November 2024
Department of Cardiac Arrhythmia and Electrophysiology, San Raffaele University-Hospital, Milan, Italy.
Anesthetic Management of Intracardiac Migration of Medical Devices.
J Cardiothorac Vasc Anesth
July 2024
Department of Anesthesiology, The Ohio State University, Columbus, OH.
The use of endovascular, percutaneous interventions to treat cardiac, arterial, and venous pathologies is becoming increasingly common in medical practice. While endovascular device placement typically carries a low risk, device migration remains a persistent problem with these procedures for which anesthesia providers must have a high index of suspicion. Anesthesia providers should be aware of the wide range of indications for such devices, potential migration locations, and hemodynamic consequences of both the inciting pathology and device migration so they can safely care for patients in these settings.
View Article and Find Full Text PDFTranscatheter non-acute retrieval of the tine-based leadless ventricular pacemaker.
Europace
October 2024
Cardiology Department, Na Homolce Hospital, Roentgenova 37/2, 15030 Prague, Czech Republic.
Article Synopsis
- - The study evaluates the mid-term to long-term retrieval and reimplantation of a leadless pacemaker (Micra TPS) in a single medical center.
- - Out of nine patients who underwent retrieval attempts after an average of 3.1 years, 88.9% were successfully retrieved, with no major complications reported.
- - The successful retrieval procedure allows for replacement with either a new Micra device or a traditional pacemaker, offering a better management option at the end of the device's life compared to simply discarding it.
Conceptual Piezoelectric-Based Energy Harvester from In Vivo Heartbeats' Cyclic Kinetic Motion for Leadless Intracardiac Pacemakers.
Micromachines (Basel)
September 2024
Department of AAU Energy, Aalborg University, 9220 Aalborg East, Denmark.
Article Synopsis
- - This paper examines the development of piezoelectric energy harvesting systems designed to replace batteries in leadless intracardiac pacemakers, fitting within the existing battery compartment.
- - The study uses three-dimensional finite element analysis and in-vivo heart measurements to assess power output, finding that heart motion can be harnessed as a renewable energy source.
- - Key findings indicate that the energy harvester can generate 1.1 V by capturing energy from periodic cardiac motion, suggesting a promising future for self-powered medical devices like pacemakers.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!